GLP-1 medications
GLP-1 is a hormone your gut releases after you eat — it tells your brain you're full and helps your body manage blood sugar. GLP-1 medications (semaglutide, tirzepatide, and newer molecules) copy that signal, which is why they're so widely studied for weight management and metabolic health.
The articles below explain how these medications work, what the research actually shows, and what side effects and dosing schedules look like in practice. Promise offers compounded GLP-1 medications by prescription only: a licensed provider reviews every request, and not everyone qualifies.
331 articles on this topic
-

ASC30 Diabetes Results: What the New Trial Means
Ascletis reported early blood-sugar and weight results for its experimental daily pill. Here’s what the findings mean alongside treatments prescribed today.
-

Retatrutide vs Ozempic: What the New Trial Shows
Lilly reported greater weight loss and blood-sugar reductions with retatrutide in a direct diabetes trial. The analysis assumes continued treatment, and side effects matter too.
-

Tradipitant GLP-1: Less Vomiting, With a Catch
Tradipitant reduced vomiting in a new semaglutide study. Its unusual starting dose limits what the result means for everyday treatment.
-

Wegovy Pill Prescribing Information: What It Says
Novo Nordisk's June 2026 package insert combines the weekly Wegovy shot and the daily Wegovy tablet into one document. Here is what the tablet sections say about uses, morning dosing rules, side effects, and safety warnings.
-

What Is Immunogenicity? Meaning for Peptides and GLP-1s
Immunogenicity is a medicine's tendency to trigger an immune response against itself. Here is how antibody findings differ from allergy symptoms on peptide and GLP-1 labels.
-

The Ozempic Gastroparesis Study: What JAMA Found
The 2023 JAMA paper behind 'stomach paralysis' headlines was an insurance-claims letter, not a clinical trial. Here is what its numbers actually showed — and what later studies found.
-

Controlled Substances Act 1970: Are Peptides Scheduled?
President Nixon signed the Controlled Substances Act on October 27, 1970 to create five federal drug schedules. Semaglutide, tirzepatide, and sermorelin are not on those lists, though prescription and state rules still apply.
-

Thanksgiving on Tirzepatide: Dinner and Doses
Holiday dinner can feel different on tirzepatide. The label facts explain fullness, stomach symptoms, dose timing and medicine storage around guests.
-

FibroScan Results Explained: Fat and Scarring
CAP estimates liver fat; stiffness helps assess scarring. Here’s how FibroScan, FIB-4, MRI and biopsy numbers fit together, with examples from trials.
-

Nobel Prize for Insulin: What Happened in 1923
Banting and Macleod won the 1923 prize for a discovery built by a Toronto team. The dated telegram explains the anniversary; the later milestones explain its connection to GLP-1 medicines.
-

Foundayo Prescribing Information, Explained
Foundayo’s label describes a daily weight-management pill, gradual dose increases and specific interaction checks. Here’s what each key section means.
-

GLP-1 After Bariatric Surgery: A Provider’s Review
Weight regain can lead to another treatment discussion. Surgery type, reflux, nutrition, and blood-sugar history shape whether a GLP-1 fits.
-

Can You Donate Blood on Semaglutide? Usually, Yes
Semaglutide usually does not rule out blood donation. Feeling well, meeting donor screening rules, and reviewing other medicines still matter.
-

Flying With Tirzepatide: TSA and Storage Rules
Tirzepatide can travel in a carry-on. The details depend on TSA screening, the actual medication label, elapsed hours between doses, and destination rules.
-

Sugar Cravings on Semaglutide: Halloween Candy?
The labels don't forbid sweets, and a sweet tooth isn't a treatment score. Halloween planning is about comfort, blood sugar and medicines around children.
-

DEXA Scan Results Explained: What the Numbers Mean
A DEXA report separates fat, lean tissue and bone. Here’s what the numbers mean, how they changed in trials and why lean mass isn’t muscle alone.
-

What Is an NDC Number? How to Read a Drug Code
An NDC identifies a drug’s labeler, product and package. It does not prove approval, authenticity or insurance coverage—and compounded prescriptions follow different listing rules.
-

Tirzepatide and Periods: Why Your Cycle Can Change
Period changes have been reported with tirzepatide, though they are not listed as human side effects in its labels. Weight changes, contraception and pregnancy also matter.
-

Rybelsus Prescribing Information, Explained
The Rybelsus label also covers Ozempic tablets. Here are the different strengths, labeled uses, timing rules, warnings and side-effect rates in plain words.
-

STEP TEENS Trial: BMI Fell 16.1% Over 68 Weeks
Teenagers receiving semaglutide had a 16.1% average BMI reduction versus a 0.6% rise with placebo. Side effects and unanswered questions matter too.
Page 4 of 17 · 331 articles